Compare KURA & MQY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KURA | MQY |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 744.0M | 836.1M |
| IPO Year | 2015 | 1994 |
| Metric | KURA | MQY |
|---|---|---|
| Price | $8.95 | $11.65 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $26.88 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 305.1K |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,482,000.00 | N/A |
| Revenue This Year | $124.03 | N/A |
| Revenue Next Year | $28.63 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.24 | N/A |
| 52 Week Low | $5.41 | $10.52 |
| 52 Week High | $12.49 | $11.97 |
| Indicator | KURA | MQY |
|---|---|---|
| Relative Strength Index (RSI) | 58.06 | 42.97 |
| Support Level | $8.09 | $11.49 |
| Resistance Level | $10.50 | $11.78 |
| Average True Range (ATR) | 0.39 | 0.10 |
| MACD | 0.09 | -0.02 |
| Stochastic Oscillator | 96.49 | 9.46 |
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
Blackrock Muniyield Quality Fund Inc is a closed-end management investment company. The company's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Corporate, Health, Utilities, Education, Housing, and other sectors.